HCPCS Code Details - J9359

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9359
Description

Long description:
Injection, loncastuximab tesirine-lpyl, 0.075 mg

Short description:
Inj lon tesirin-lpyl 0.075mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code A - Add procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Apr 01, 2022
Date added Added Apr 01, 2022
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J9359

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
April 1, 2022 - June 30, 2022 0.075 MG 186.83 - - - - - -

See also

  • HCPCS J9358 · Injection, fam-trastuzumab deruxtecan-nxki, 1 mg

  • HCPCS C9084 · Injection, loncastuximab tesirine-lpyl, 0.1 mg

  • HCPCS J9360 · Injection, vinblastine sulfate, 1 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”